From the Journals

Groups release guidelines for CAR T treatment in children

Publish date: August 10, 2018

 

FROM NATURE REVIEWS CLINICAL ONCOLOGY

SOURCE: Mahadeo KM et al. Nat Rev Clin Oncol. 2018 Aug 6. doi: 10.1038/s41571-018-0075-2.

Pages

Recommended Reading

Inherited thrombocytopenia type is a risk factor for hematologic cancers
MDedge Pediatrics
VIDEO: Anti-CD22 CAR for R/R ALL impresses in early trial
MDedge Pediatrics
Treatment-related hypertension, kidney injury are undertreated in kids with leukemia
MDedge Pediatrics
MRD better measure of ALL remission than morphology
MDedge Pediatrics
FDA approves first gene therapy – tisagenlecleucel for ALL
MDedge Pediatrics
In children with ALL, physical and emotional effects persist
MDedge Pediatrics
Flu vaccine did not protect children with acute leukemia
MDedge Pediatrics
Relapse rate drives stem cell transplant failure in pediatric ALL patients
MDedge Pediatrics
Pediatric cancers are on the rise
MDedge Pediatrics
New regimens for youth with T-cell malignancies yield best outcomes yet
MDedge Pediatrics